Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 2
2003 2
2004 2
2005 1
2007 2
2008 2
2009 6
2010 2
2011 5
2012 4
2013 5
2014 4
2015 2
2016 2
2017 5
2018 1
2019 3
2020 2
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Stenting and medical therapy for atherosclerotic renal-artery stenosis.
Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, Cohen DJ, Matsumoto AH, Steffes M, Jaff MR, Prince MR, Lewis EF, Tuttle KR, Shapiro JI, Rundback JH, Massaro JM, D'Agostino RB Sr, Dworkin LD; CORAL Investigators. Cooper CJ, et al. N Engl J Med. 2014 Jan 2;370(1):13-22. doi: 10.1056/NEJMoa1310753. Epub 2013 Nov 18. N Engl J Med. 2014. PMID: 24245566 Free PMC article. Clinical Trial.
BACKGROUND: Atherosclerotic renal-artery stenosis is a common problem in the elderly. Despite two randomized trials that did not show a benefit of renal-artery stenting with respect to kidney function, the usefulness of stenting …
BACKGROUND: Atherosclerotic renal-artery stenosis is a common problem in the elderly. Despite two randomized tri …
Drug-coated balloon for treatment of non-atherosclerotic renal artery stenosis-a multi-center study.
Song X, Fu Y, Lai Z, Di X, Zeng R, Shao J, Ni L, Liu Z, Song X, Ye W, Liu C, Liu B, Zheng Y, Chen Y. Song X, et al. BMC Cardiovasc Disord. 2023 Oct 16;23(1):510. doi: 10.1186/s12872-023-03484-5. BMC Cardiovasc Disord. 2023. PMID: 37845604 Free PMC article.
INTRODUCTION: Renal artery stenosis (RAS) is a significant reason for secondary hypertension. ...Drug-coated balloon (DCB) has been proven to be effective in restenosis prevention in femoropopliteal arterial diseases and in patients with renal arter …
INTRODUCTION: Renal artery stenosis (RAS) is a significant reason for secondary hypertension. ...Drug-coated balloon (D …
Renal artery stenosis in patients with resistant hypertension.
Protasiewicz M, Kądziela J, Początek K, Poręba R, Podgórski M, Derkacz A, Prejbisz A, Mysiak A, Januszewicz A, Witkowski A. Protasiewicz M, et al. Am J Cardiol. 2013 Nov 1;112(9):1417-20. doi: 10.1016/j.amjcard.2013.06.030. Am J Cardiol. 2013. PMID: 24135303 Clinical Trial.
The aim of the study was to assess the significance of renal translesional pressure gradients in predicting improvement in resistant hypertension after stenting for moderate renal artery stenosis (RAS). In 37 patients with RAS and resistant hype …
The aim of the study was to assess the significance of renal translesional pressure gradients in predicting improvement in resistant …
Determinants of renal function in patients with renal artery stenosis.
Yu H, Zhang D, Haller S, Kanjwal K, Colyer W, Brewster P, Steffes M, Shapiro JI, Cooper CJ. Yu H, et al. Vasc Med. 2011 Oct;16(5):331-8. doi: 10.1177/1358863X11419998. Epub 2011 Sep 9. Vasc Med. 2011. PMID: 21908683 Clinical Trial.
Renal artery stenosis (RAS) is an important cause of renal failure; however, the factors associated with loss of kidney function in patients with RAS are poorly described, as are the predictors of an improvement in kidney function after stenting …
Renal artery stenosis (RAS) is an important cause of renal failure; however, the factors associated with loss of …
Effect of renal artery stenting on left ventricular mass: a randomized clinical trial.
Marcantoni C, Zanoli L, Rastelli S, Tripepi G, Matalone M, Mangiafico S, Capodanno D, Scandura S, Di Landro D, Tamburino C, Zoccali C, Castellino P. Marcantoni C, et al. Am J Kidney Dis. 2012 Jul;60(1):39-46. doi: 10.1053/j.ajkd.2012.01.022. Epub 2012 Apr 10. Am J Kidney Dis. 2012. PMID: 22495466 Clinical Trial.
STUDY DESIGN: Randomized clinical trial testing the effect of renal artery stenting versus medical therapy on left ventricular hypertrophy progression in patients affected by ischemic heart disease and renal artery stenosis. …
STUDY DESIGN: Randomized clinical trial testing the effect of renal artery stenting versus medical therap …
Renal Artery Stent Outcomes: Effect of Baseline Blood Pressure, Stenosis Severity, and Translesion Pressure Gradient.
Murphy TP, Cooper CJ, Matsumoto AH, Cutlip DE, Pencina KM, Jamerson K, Tuttle KR, Shapiro JI, D'Agostino R, Massaro J, Henrich W, Dworkin LD. Murphy TP, et al. J Am Coll Cardiol. 2015 Dec 8;66(22):2487-94. doi: 10.1016/j.jacc.2015.09.073. J Am Coll Cardiol. 2015. PMID: 26653621 Free PMC article. Clinical Trial.
BACKGROUND: Multiple randomized clinical trials comparing renal artery stent placement plus medical therapy with medical therapy alone have not shown any benefit of stent placement. ...OBJECTIVES: The study sought to test the hypothesis that pre …
BACKGROUND: Multiple randomized clinical trials comparing renal artery stent placement plus medical therapy with …
Clinical predictors of blood pressure response after renal artery stenting.
Modrall JG, Zhu H, Weaver FA. Modrall JG, et al. J Vasc Surg. 2020 Oct;72(4):1269-1275. doi: 10.1016/j.jvs.2019.12.041. Epub 2020 Mar 2. J Vasc Surg. 2020. PMID: 32139312 Free article.
OBJECTIVE: The Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) trial, a multicenter randomized controlled trial, failed to demonstrate a benefit of renal artery stenting (RAS) over medical therapy in patient …
OBJECTIVE: The Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) trial, a multicenter randomized cont …
Use of renin-angiotensin inhibitors in people with renal artery stenosis.
Evans KL, Tuttle KR, Folt DA, Dawson T, Haller ST, Brewster PS, He W, Jamerson K, Dworkin LD, Cutlip DE, Murphy TP, D'Agostino RB Sr, Henrich W, Cooper CJ. Evans KL, et al. Clin J Am Soc Nephrol. 2014 Jul;9(7):1199-206. doi: 10.2215/CJN.11611113. Epub 2014 Jun 5. Clin J Am Soc Nephrol. 2014. PMID: 24903387 Free PMC article. Clinical Trial.
BACKGROUND AND OBJECTIVES: People with atherosclerotic renal artery stenosis may benefit from renin-angiotensin inhibitors, angiotensin-converting enzyme inhibitors, and angiotensin-receptor blockers, but little is known about the factors associated with thei …
BACKGROUND AND OBJECTIVES: People with atherosclerotic renal artery stenosis may benefit from renin-angiotensin inhibit …
Early Rapid Decline in Kidney Function in Medically Managed Patients With Atherosclerotic Renal Artery Stenosis.
Cooper EL, Xie Y, Nguyen H, Brewster PS, Sholl H, Sharrett M, Ren K, Chen T, Tuttle KR, Haller ST, Jamerson K, Murphy TP, D'Agostino RB Sr, Massaro JM, Henrich W, Cooper CJ, Cutlip DE, Dworkin LD, Shapiro JI. Cooper EL, et al. J Am Heart Assoc. 2019 Jun 4;8(11):e012366. doi: 10.1161/JAHA.119.012366. Epub 2019 Jun 1. J Am Heart Assoc. 2019. PMID: 31433717 Free PMC article. Clinical Trial.
Background Early rapid declines of kidney function may occur in patients with atherosclerotic renal artery stenosis with institution of medical therapy. The causes and consequences are not well understood. ...Conclusions Early rapid declines in kidney functio …
Background Early rapid declines of kidney function may occur in patients with atherosclerotic renal artery stenosis wit …
Revascularization versus medical therapy for renal-artery stenosis.
ASTRAL Investigators; Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, Baigent C, Carr S, Chalmers N, Eadington D, Hamilton G, Lipkin G, Nicholson A, Scoble J. ASTRAL Investigators, et al. N Engl J Med. 2009 Nov 12;361(20):1953-62. doi: 10.1056/NEJMoa0905368. N Engl J Med. 2009. PMID: 19907042 Free article. Clinical Trial.
METHODS: In a randomized, unblinded trial, we assigned 806 patients with atherosclerotic renovascular disease either to undergo revascularization in addition to receiving medical therapy or to receive medical therapy alone. ...Secondary outcomes were blood pressure, …
METHODS: In a randomized, unblinded trial, we assigned 806 patients with atherosclerotic renovascular disease either to underg …
50 results